Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Dec 6, 2020; 8(23): 5935-5943
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5935
Table 1 Relationship between CD155 expression and pathological characteristics
CD155 expression
P value

Negative (n = 78)
Positive (n = 48)
Age1, mean ± SD (yr)58.2 ± 13.8757.8 ± 13.260.914
Histological grade2, n (%)0.112
I11 (15.3)2 (4.3)
II47 (65.3)32 (69.6)
III14 (19.4)12 (26.1)
TNM stage2, n (%)0.662
I20 (27.0)10 (21.3)
II39 (52.7)28 (59.6)
III12 (16.2)6 (12.8)
IV3 (4.1)3 (6.4)
Molecular subtype3, n (%)0.002
Luminal A49 (77.8)14 (22.2)
Luminal B16 (51.6)15 (48.4)
HER2 over-expression5 (50.0)5 (50.0)
Triple negative3 (27.3)8 (72.7)